CymaBay Therapeutics Earning Date (CBAY)

USA |NASDAQ |USD

CBAY Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 23, 2022 Dec 2021 $-0.25 - $-0.23
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 23, 2022 Dec 2021 $8.75M - $0.00

Cymabay Therapeutics's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 2021.

CBAY Earnings Date & History Chart

CBAY Earnings & Revenue Forecast

CBAY Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.25 $-0.38 $0.26
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-1.07 $-1.33 $-0.32
Dec 2022 8 $-1.39 $-1.57 $-1.05

CBAY Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.25 $-0.31 $-0.32
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.07 $-1.12 $-1.12
Dec 2022 0 / 0 $-1.39 $-1.15 $-1.14

CBAY Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $8.75M $0.00 $45.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $15.00M $0.00 $70.00M
Dec 2022 7 $4.29M $0.00 $30.00M

CBAY Earnings Date & Revenue History

CBAY Earnings History

|
Show More
Show More

CBAY Revenue History

|
Show More
Show More

Cymabay Therapeutics Next Earnings Date & Report

CBAY Next Earnings Date & Report Preview: Dec 2021 (FQ)

CBAY's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Cymabay Therapeutics's next quarterly earnings is $-0.25, with a low EPS estimation of $-0.38, and a high estimation of $0.26.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.25, the last 2 month trend is $-0.31, and the 3 month trend is $-0.32.

Based on analysts, the average revenue estimation is $8.75M, with a low revenue estimation of $0.00, and a high estimation of $45.00M.

Cymabay Therapeutics Previous Earnings Dates & Reports

CBAY Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Cymabay Therapeutics's previous earnings date was Nov 3, 2021 for its fiscal quarter ended Sep 30, 2021.

CBAY Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cymabay Therapeutics's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

CBAY's earnings per share (EPS) was $-0.75, missing the consensus analysts forecast of $-0.71 by 5.63% , and higher than the previous year's EPS (Dec 2019) by -48.42%.

Revenues were $0.00.

The company reported a net income of $-50.99M.

Cymabay Therapeutics reported a free cash flow of $-44.75M for its fiscal year, compared to $-98.23M a year ago.

The company ended the fiscal year with $1.74M in total debt, a decrease of -18.88% compared to the previous year.